Pfizer has tapped Wall Street analyst Andrew Baum to be its new chief strategy and innovation officer, where he’ll head up management of the company’s portfolio and work on partnerships.
Baum has been an investment analyst for more than two decades, most recently at Citi, where he led the bank’s healthcare research. Previously, he spent 14 years at Morgan Stanley and has also been a working physician.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.